Tech and Market Highlights: On Semiconductor Soars, Teslas Steady Growth, and More
Generated by AI AgentAinvest Market Brief
Monday, Jul 29, 2024 6:30 pm ET1min read
C--
ON--
RMD--
1. On Semiconductor (Nasdaq: ON)
On Semiconductor surged by 11.54%. On Semiconductor reported second-quarter fiscal 2024 results, with adjusted EPS of $0.96 surpassing analyst expectations of $0.92. Susquehanna maintains a positive rating with a $95.00 price target, while Citigroup downgraded the stock to neutral, setting a $77.00 price target.
2. Resmed (NYSE: RMD)
Resmed gained solidly by 5.85%. ResMed reported Q3 2024 revenue of $3.462 billion, up 11.65% year-over-year, with a net profit of $729 million. RBC Capital maintains Sector Perform on ResMed with a $204 target. Oppenheimer and Citigroup downgraded ResMed to Perform and Neutral, respectively. Insider transactions were disclosed in July.
3. Tesla (Nasdaq: TSLA)
Tesla gained solidly by 5.6%. Tesla released its mid-2024 report, showing a revenue of $46.801 billion, down 3.02% year-on-year, and a net profit of $26 billion. Morgan Stanley reiterated an Overweight rating with a $310 price target. Tesla may reapply for insurance brokerage registration in China.
4. Mcdonald'S (NYSE: MCD)
Mcdonald'S gained solidly by 3.76%. TD Cowen reiterates buy rating for McDonald's with a target price of $285. Wedbush maintains outperform rating with a target of $295. McDonald's Q2 2024 revenue dropped to $64.9 billion from last year's $65 billion, marking the first decline since 2020.
5. Alibaba Group Holding Limited (NYSE: BABA)
Alibaba Group Holding Limited gained mildly by 2.76%. Chinese companies are seizing new opportunities amid the Paris Olympics. Ctrip reported a 114% YOY increase in travel orders for Paris. Alibaba's presence is prominent at the games, with significant advertising visibility and exports through Alibaba International Station. Jefferies maintains a "buy" rating for Alibaba.
On Semiconductor surged by 11.54%. On Semiconductor reported second-quarter fiscal 2024 results, with adjusted EPS of $0.96 surpassing analyst expectations of $0.92. Susquehanna maintains a positive rating with a $95.00 price target, while Citigroup downgraded the stock to neutral, setting a $77.00 price target.
2. Resmed (NYSE: RMD)
Resmed gained solidly by 5.85%. ResMed reported Q3 2024 revenue of $3.462 billion, up 11.65% year-over-year, with a net profit of $729 million. RBC Capital maintains Sector Perform on ResMed with a $204 target. Oppenheimer and Citigroup downgraded ResMed to Perform and Neutral, respectively. Insider transactions were disclosed in July.
3. Tesla (Nasdaq: TSLA)
Tesla gained solidly by 5.6%. Tesla released its mid-2024 report, showing a revenue of $46.801 billion, down 3.02% year-on-year, and a net profit of $26 billion. Morgan Stanley reiterated an Overweight rating with a $310 price target. Tesla may reapply for insurance brokerage registration in China.
4. Mcdonald'S (NYSE: MCD)
Mcdonald'S gained solidly by 3.76%. TD Cowen reiterates buy rating for McDonald's with a target price of $285. Wedbush maintains outperform rating with a target of $295. McDonald's Q2 2024 revenue dropped to $64.9 billion from last year's $65 billion, marking the first decline since 2020.
5. Alibaba Group Holding Limited (NYSE: BABA)
Alibaba Group Holding Limited gained mildly by 2.76%. Chinese companies are seizing new opportunities amid the Paris Olympics. Ctrip reported a 114% YOY increase in travel orders for Paris. Alibaba's presence is prominent at the games, with significant advertising visibility and exports through Alibaba International Station. Jefferies maintains a "buy" rating for Alibaba.
Market Watch column provides a thorough analysis of stock market fluctuations and expert ratings.
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet